Dr. Shruti Bhatt is an Assistant Professor at National University of Singapore in the Department of Pharmacy. Her research lab focuses on understanding the genetic and non-genetic mechanism of resistance to targeted therapy and developing new therapeutic strategies for relapsed leukemia. She completed postdoctoral training in the laboratory of Dr. Anthony Letai at Dana-Farber where she worked on personalizing leukemia therapy by exploiting the mitochondrial pathway of apoptosis. She obtained PhD in Pharmacology from University of Miami where she trained under Dr. Izidore Lossos and developed a novel antibobdy-cytokine fusion protein to target lymphoid tumors. She is recipient of 2016 LLS Career Development Fellow Award, 2018 EHA/ASH Translational Research Training in Hematology Award, 2019 Forbeck Scholar Award, 2021 AACR Nextgen Stars Award, 2021 ASH Global Research Award, and 2022 EMBO Global Investigator Award. She acknowledges funding support from NMRC and MOE.